- Indication
- Diabetes type 1
- RAG rating
- n/a
- Document type
- NICE technology appraisal
- Place
- Hertfordshire and West Essex ICB
- Output type
- Clinical Policies & Evidence-based Interventions
Hybrid closed loop systems for managing blood glucose levels
Hertfordshire and West Essex ICB are aware of the recently published updated National Institute for Health and Care Excellence (NICE) Technology Appraisal (TA) 943: Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. Consultation with local stakeholders including commissioning, hospital and community specialists will be undertaken concerning the new NICE TA recommendations and development of a 5-year implementation plan. In line with accepted and required governance processes for local decision making, any revised guidelines will require review and approval by Hertfordshire and West Essex Area Prescribing Committee or Clinical Policies Group and ratification by Hertfordshire and West Essex ICB.
In the interim, clinicians are advised to continue to follow existing local guidelines .Please be assured that any update to local guidelines will be published on the Hertfordshire and West Essex ICB Prescribing, Policies and Pathways website (Prescribing, Policies and Pathways (hweclinicalguidance.nhs.uk)) and cascaded to local clinicians.
NICE TA 943: Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes published 19 December 2023